Stacie is a dynamic leader and researcher with 25+ years of diverse experience in biotechnology, academic, nonprofit and pharma in discovery research, drug and device development, scientific strategy, education and patient centricity with a cross functional focus on clinical development and medical affairs. She has been involved with all phases and functional lines of the pre-clinical research and clinical development process in several therapeutic areas, including infectious diseases, immunology, rheumatology, dermatology, and has worked extensively with the FDA, NIH and NHC. Stacie currently leads Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance and oversees the LuCIN clinical trial network, a variety of partnerships advancing treatment development in lupus, and the patient engagement and health equity functions for the LRA. She has served in several leadership roles including Chief Scientific & Medical Officer for the National Psoriasis Foundation, on numerous boards and committees, consulted for late-stage discovery and clinical development programs in a variety of settings and has been the therapeutic area representative and program lead for her organizations. Stacie received her doctorate in biochemistry from Vanderbilt University and has secondary training in Clinical Pharmacology and Research. Throughout her career she has been dedicated to optimizing treatment options for unmet needs, promoting education, improving access to care, fostering partnership to progress programs and taking innovative approaches for program strategy.